Ilaria R L, Van Etten R A
Division of Hematology/Oncology, Department of Medicine, Brigham and Women's Hospital, Massachusetts 02115, USA.
J Biol Chem. 1996 Dec 6;271(49):31704-10. doi: 10.1074/jbc.271.49.31704.
The products of the Philadelphia chromosome translocation, P210 and P190(BCR/ABL), are cytoplasmic protein tyrosine kinases that share the ability to transform hematopoietic cytokine-dependent cell lines to cytokine independence but differ in the spectrum of leukemia induced in vivo. We have analyzed the Janus kinase (JAK) and signal transducer and activator of transcription (STAT) pathways in hematopoietic cells transformed by Bcr/Abl. STAT5 and, to a lesser extent, STATs 1 and 3 were constitutively activated by tyrosine phosphorylation and induction of DNA binding activity in both P210 and P190(BCR/ABL)-transformed cells, but P190 differed in that it also prominently activated STAT6. There was low level tyrosine phosphorylation of JAKs 1, 2, and 3 in Bcr/Abl-transformed cells, but no detectable complex formation with Bcr/Abl, and activation of STAT5 by P210 was not blocked by two different dominant-negative JAK mutants. These results suggest that P210 and P190(BCR/ABL) directly activate specific STAT family members and may help explain their overlapping yet distinct roles in leukemogenesis.
费城染色体易位的产物P210和P190(BCR/ABL)是细胞质蛋白酪氨酸激酶,它们都具有将依赖造血细胞因子的细胞系转化为不依赖细胞因子的能力,但在体内诱导的白血病谱方面存在差异。我们分析了由Bcr/Abl转化的造血细胞中的Janus激酶(JAK)和信号转导及转录激活因子(STAT)途径。在P210和P190(BCR/ABL)转化的细胞中,STAT5以及程度较轻的STAT1和STAT3通过酪氨酸磷酸化和DNA结合活性的诱导而组成性激活,但P190的不同之处在于它还显著激活STAT6。在Bcr/Abl转化的细胞中,JAK1、JAK2和JAK3存在低水平的酪氨酸磷酸化,但未检测到与Bcr/Abl形成复合物,并且P210对STAT5的激活未被两种不同的显性负性JAK突变体阻断。这些结果表明,P210和P190(BCR/ABL)直接激活特定的STAT家族成员,这可能有助于解释它们在白血病发生中重叠但又不同的作用。